Literature DB >> 20693195

Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets.

J Wenzel1, S Zahn, T Tüting.   

Abstract

The term 'cutaneous lupus erythematosus' (CLE) comprises several related autoimmune skin disorders, defined as 'specific' skin manifestations of lupus erythematosus (LE). The spectrum of clinical presentation of CLE is wide, reaching from mild erythema to disseminated scarring skin lesions. There is increasing knowledge concerning the pathogenesis of LE skin lesions and it has been shown that a complex network of cutaneous cytokines, chemokines and adhesion molecules orchestrate and promote tissue injury observed in LE skin lesions. However, a complete understanding of the diverse pathophysiological mechanisms in the different CLE subsets does not exist. Here we review the main pathological features described in CLE patients against the background of the clinical diversity of different CLE subtypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20693195     DOI: 10.1177/0961203310370046

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

1.  Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

Authors:  Eneida Villanueva; Srilakshmi Yalavarthi; Celine C Berthier; Jeffrey B Hodgin; Ritika Khandpur; Andrew M Lin; Cory J Rubin; Wenpu Zhao; Stephen H Olsen; Matthew Klinker; David Shealy; Michael F Denny; Joel Plumas; Laurence Chaperot; Matthias Kretzler; Allen T Bruce; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

2.  [Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus].

Authors:  M Sticherling
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

Review 3.  Endothelial Dysfunction Induced by Extracellular Neutrophil Traps Plays Important Role in the Occurrence and Treatment of Extracellular Neutrophil Traps-Related Disease.

Authors:  Shuyang Yu; Jingyu Liu; Nianlong Yan
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

4.  Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus.

Authors:  Rita Quelhas da Costa; M Elena Aguirre-Alastuey; David A Isenberg; Amanda M Saracino
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

Review 5.  Lupus erythematosus revisited.

Authors:  Annegret Kuhn; Joerg Wenzel; Marc Bijl
Journal:  Semin Immunopathol       Date:  2015-12-04       Impact factor: 11.759

6.  Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease.

Authors:  Eva N Hadaschik; Xiaoying Wei; Harald Leiss; Britta Heckmann; Birgit Niederreiter; Günter Steiner; Walter Ulrich; Alexander H Enk; Josef S Smolen; Georg H Stummvoll
Journal:  Arthritis Res Ther       Date:  2015-02-23       Impact factor: 5.156

Review 7.  Cutaneous lupus erythematosus: An update.

Authors:  Carina M Grönhagen; Filippa Nyberg
Journal:  Indian Dermatol Online J       Date:  2014-01

8.  Lupus erythematosus tumidus: clinical perspectives.

Authors:  Nikolaos Patsinakidis; Ocko Kautz; Bernhard F Gibbs; Ulrike Raap
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-10-01

9.  Genome-wide transcriptional profiling data from chronic cutaneous lupus erythematosus (CCLE) peripheral blood.

Authors:  R Dey-Rao; A A Sinha
Journal:  Data Brief       Date:  2014-12-11

Review 10.  Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Authors:  S C Hofmann; M J Leandro; S D Morris; D A Isenberg
Journal:  Lupus       Date:  2013-08       Impact factor: 2.911

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.